Emily W. Chan
Impact in
- Oncology top 0.5%
- Colorectal Cancer Treatments and Studies
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Surgical Treatments
- Cancer Research top 2%
- Cancer Genomics and Diagnostics
Papers in
- Co-authors
- Michael Andrew Morse (2 shared papers)Ahmed L. Aboul Nasr (10 shared papers)Carolyn Wayne (7 shared papers)Christine H. Chung (2 shared papers)Shama M. Satinover (1 shared paper)Quynh‐Thu Le (1 shared paper)Thomas A.E. Platts‐Mills (1 shared paper)David M. Mauro (1 shared paper)
- Journals
- Journal of the National Comprehensive Cancer Network (4 papers)Journal of Medicinal Chemistry (4 papers)Journal of Clinical Oncology (4 papers)Investigational New Drugs (4 papers)Clinical Cancer Research (3 papers)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Emily W. Chan
93 papers receiving 8.4k citations
Emily W. Chan's Hit Papers
Peers
Comparison fields: 5 of 138
- Oncology 3.3k
- Cancer Research 911
- Immunology and Allergy 380
- Pathology and Forensic Medicine 888
- Surgery 1.8k
Countries citing papers authored by Emily W. Chan
This map shows the geographic impact of Emily W. Chan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily W. Chan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily W. Chan more than expected).
Fields of papers citing papers by Emily W. Chan
This network shows the impact of papers produced by Emily W. Chan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily W. Chan. The network helps show where Emily W. Chan may publish in the future.
Co-authors
The 25 scholars most cited alongside Emily W. Chan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 95 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Vemurafenib in Multiple Nonmelanoma Cancers with BRAF V600 Mutations Hit paper breakdown → | 2015 | 1472 |
| 2 | Cetuximab-Induced Anaphylaxis and IgE Specific for Galactose-α-1,3-Galactose Hit paper breakdown → | 2008 | 1237 |
| 3 | Phase II Pilot Study of Vemurafenib in Patients With Metastatic BRAF -Mutated Colorectal Cancer Hit paper breakdown → | 2015 | 593 |
| 4 | Nivolumab monotherapy in recurrent metastatic urothelial carcinoma (CheckMate 032): a multicentre, open-label, two-stage, multi-arm, phase 1/2 trial Hit paper breakdown → | 2016 | 569 |
| 5 | Nivolumab for previously treated unresectable metastatic anal cancer (NCI9673): a multicentre, single-arm, phase 2 study Hit paper breakdown → | 2017 | 315 |
| 6 | 2018 | 257 | |
| 7 | 2011 | 224 | |
| 8 | 2017 | 201 | |
| 9 | 2014 | 192 | |
| 10 | 2003 | 184 | |
| 11 | 2005 | 169 | |
| 12 | 2020 | 167 | |
| 13 | 2015 | 156 | |
| 14 | 2019 | 149 | |
| 15 | An allosteric pan-TEAD inhibitor blocks oncogenic YAP/TAZ signaling and overcomes KRAS G12C inhibitor resistance Hit paper breakdown → | 2023 | 142 |
| 16 | 2012 | 127 | |
| 17 | 2017 | 127 | |
| 18 | 2022 | 112 | |
| 19 | 2017 | 110 | |
| 20 | 1995 | 105 |
About Emily W. Chan
Emily W. Chan is a scholar working on Oncology, Surgery, Pathology and Forensic Medicine, Molecular Biology and Pulmonary and Respiratory Medicine, having authored 95 papers that have together received 8.8k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (12 papers), Pancreatic and Hepatic Oncology Research (8 papers), Colorectal and Anal Carcinomas (8 papers), Protein Degradation and Inhibitors (7 papers), Genetic factors in colorectal cancer (5 papers), Congenital Diaphragmatic Hernia Studies (4 papers), COVID-19 and healthcare impacts (4 papers) and Colorectal Cancer Surgical Treatments (3 papers). The work is most often cited by research in Oncology (3.3k citations), Cancer Research (911 citations), Immunology and Allergy (380 citations), Pathology and Forensic Medicine (888 citations) and Surgery (1.8k citations). Emily W. Chan has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Michael Andrew Morse, Ahmed L. Aboul Nasr, Carolyn Wayne, Christine H. Chung, Shama M. Satinover, Quynh‐Thu Le, Thomas A.E. Platts‐Mills, David M. Mauro, Daniel J. Hicklin and Tina K. Hatley. Their work appears in journals such as Journal of the National Comprehensive Cancer Network, Journal of Medicinal Chemistry, Journal of Clinical Oncology, Investigational New Drugs and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.